Misbah Tahir
Chief Financial Officer · Maze Therapeutics, Inc.
- 2024
- Mar 3, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Misbah Tahir files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Harold Bernstein - $7.44M in MAZE purchases and sales in the last 12 months
- Jason V. Coloma - $6.19M in MAZE purchases and sales in the last 12 months
- Atul Dandekar - $2.27M in MAZE purchases and sales in the last 12 months
- Catherine A. Sohn - $1.15M in MAZE purchases and sales in the last 12 months
- Amy Bachrodt - $757K in MAZE purchases and sales in the last 12 months
- Phillips Courtney - $105K in MAZE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Misbah Tahir?
Misbah Tahir is a corporate insider, tracked as Chief Financial Officer of Maze Therapeutics, Inc. (MAZE). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Misbah Tahir last file a Form 4?
The most recent primary Form 4 on record is dated 3 March 2026, one of 5 filings going back to 2024.
Has Misbah Tahir been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($24K) across all tracked filings.
